000 | 01393 a2200409 4500 | ||
---|---|---|---|
005 | 20250512083359.0 | ||
264 | 0 | _c19850814 | |
008 | 198508s 0 0 eng d | ||
022 | _a0014-2999 | ||
024 | 7 |
_a10.1016/0014-2999(85)90556-4 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHarron, D W | |
245 | 0 | 0 |
_aAntifibrillatory properties of alinidine after coronary artery occlusion in rats. _h[electronic resource] |
260 |
_bEuropean journal of pharmacology _cApr 1985 |
||
300 |
_a301-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aAnti-Arrhythmia Agents |
650 | 0 | 4 |
_aArrhythmias, Cardiac _xetiology |
650 | 0 | 4 |
_aCardiovascular Agents _xpharmacology |
650 | 0 | 4 |
_aClonidine _xanalogs & derivatives |
650 | 0 | 4 |
_aCoronary Disease _xcomplications |
650 | 0 | 4 | _aElectrocardiography |
650 | 0 | 4 |
_aHeart Rate _xdrug effects |
650 | 0 | 4 |
_aHemodynamics _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMexiletine _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Inbred Strains |
650 | 0 | 4 | _aRisk |
650 | 0 | 4 |
_aVentricular Fibrillation _xdrug therapy |
700 | 1 | _aBrezina, M | |
700 | 1 | _aLillie, C | |
700 | 1 | _aKobinger, W | |
773 | 0 |
_tEuropean journal of pharmacology _gvol. 110 _gno. 3 _gp. 301-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0014-2999(85)90556-4 _zAvailable from publisher's website |
999 |
_c4012737 _d4012737 |